Cargando…

Antitumor necrosis factor treatment in patients with inflammatory bowel disease does not promote psoriasis development: A meta-analysis

BACKGROUND: Recent case reports have suggested that anti-tumor necrosis factor (TNF) agents are associated with an increased risk of developing psoriasis in patients with inflammatory bowel disease (IBD). AIMS: This meta-analysis of published studies aimed to evaluate the association between anti-TN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jun, Yu Kyung, Park, Joo Young, Koh, Seong-Joon, Park, Hyunsun, Kang, Hyoun Woo, Im, Jong Pil, Kim, Joo Sung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259149/ https://www.ncbi.nlm.nih.gov/pubmed/35801760 http://dx.doi.org/10.1097/MD.0000000000029872

Ejemplares similares

Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
por: Jun, Yu Kyung, et al.
Publicado: (2023)

Regulation of psoriasis, colitis, and the intestinal microbiota by clusterin
por: Jun, Yu Kyung, et al.
Publicado: (2023)

Depression in patients with inflammatory bowel disease is associated with increased risk of dementia and Parkinson’s disease: A nationwide, population-based study
por: Choi, Kookhwan, et al.
Publicado: (2022)

The Relationship Between Rosacea and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
por: Jun, Yu Kyung, et al.
Publicado: (2023)

Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea
por: Han, Yoo Min, et al.
Publicado: (2016)

Changing treatment paradigms for the management of inflammatory bowel disease
por: Im, Jong Pil, et al.
Publicado: (2018)

Toll-like receptor 4 regulates intestinal fibrosis via cytokine expression and epithelial-mesenchymal transition
por: Jun, Yu Kyung, et al.
Publicado: (2020)

Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
por: Jun, Yu Kyung, et al.
Publicado: (2023)

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
por: Al Sulais, Eman, et al.
Publicado: (2020)

Increased Risk of Diabetes in Inflammatory Bowel Disease Patients: A Nationwide Population-Based Study in Korea
por: Kang, Eun Ae, et al.
Publicado: (2019)

Effect of Probiotics on Symptoms in Korean Adults with Irritable Bowel Syndrome
por: Hong, Kyoung Sup, et al.
Publicado: (2009)

Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future
por: Lee, Jung Won, et al.
Publicado: (2015)

Impact of Crohn’s Disease on the Survival of Patients with Small-Bowel Adenocarcinoma in Korea: A Bicenter Cohort Study
por: Kim, Kyuwon, et al.
Publicado: (2023)

Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
por: Park, Seona, et al.
Publicado: (2018)

Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study
por: Lee, Jooyoung, et al.
Publicado: (2019)

Risk of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Nationwide, Population-Based Study
por: Choi, Kookhwan, et al.
Publicado: (2019)

Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
por: Soh, Hosim, et al.
Publicado: (2019)

Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson’s Disease: A South Korean Nationwide Population-Based Study
por: Park, Seona, et al.
Publicado: (2019)

Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia
por: Kim, Kwang Woo, et al.
Publicado: (2022)

Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study
por: Song, Joo Hye, et al.
Publicado: (2021)

Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study
por: Lee, Jooyoung, et al.
Publicado: (2020)

Aloe vera Is Effective and Safe in Short-term Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis
por: Hong, Seung Wook, et al.
Publicado: (2018)

Comparison of loss of response between anti-tumor necrosis factor alone and combined use with immunomodulators in patients with inflammatory bowel disease
por: Hong, Seung Wook, et al.
Publicado: (2021)

Inverse Psoriasis with Autoimmune Hepatitis
por: Seok, Joon, et al.
Publicado: (2017)

Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease
por: Lee, Ji Min, et al.
Publicado: (2022)

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
por: Kim, Hae Rim, et al.
Publicado: (2013)

Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
por: Lee, Jang Wook, et al.
Publicado: (2016)

Evaluation of Morphological Plasticity in the Cerebella of Basketball Players with MRI
por: Park, In Sung, et al.
Publicado: (2006)

Correlations between Psoriasis and Inflammatory Bowel Diseases
por: Skroza, Nevena, et al.
Publicado: (2013)

Psoriasis and inflammatory bowel disease: links and risks
por: Vlachos, Christoforos, et al.
Publicado: (2016)

Psoriasis Features in Patients with Inflammatory Bowel Disease
por: Napolitano, Maddalena, et al.
Publicado: (2019)

Changes in the Long-term Prognosis of Crohn’s Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study
por: Ye, Byong Duk, et al.
Publicado: (2022)

Medication-Related Knowledge and Medication Adherence in Pediatric and Adolescent Patients with Inflammatory Bowel Disease
por: Lim, Jong Keon, et al.
Publicado: (2020)

The Benefit of Early and Frequent Antitumor Necrosis Factor-Alpha Trough Level Determination in Very Early-Onset Inflammatory Bowel Disease
por: Gillmore, Taylor, et al.
Publicado: (2023)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
por: Park, Jihye, et al.
Publicado: (2021)

NF-kappa B activation correlates with disease phenotype in Crohn’s disease
por: Han, Yoo Min, et al.
Publicado: (2017)

Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children’s immunity
por: Lee, Ko Eun, et al.
Publicado: (2019)

Does Diabetes Mellitus Influence Standardized Uptake Values of Fluorodeoxyglucose Positron Emission Tomography in Colorectal Cancer?
por: Oh, Da Yeon, et al.
Publicado: (2014)

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease
por: Lewis, James D, et al.
Publicado: (2018)

Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease
por: Kim, Kwang Woo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t2j7jj2isfc24hljl2temki4mj